Hjem › Mavekreft › Georgia › Atlanta
Kliniske studier for Mavekreft i Atlanta, GA
14 studier for Mavekreft søker deltakere på steder i og rundt Atlanta (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
RekruttererFrivillige helsepersonell ønskes velkommen
- Northside Hospital, Atlanta
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Atlanta VA Medical Center, Decatur · 6 mi unna
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
RekruttererFase 1
- Emory Winship Cancer Institute, Atlanta
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
RekruttererFase 2/3
- Emory University, Atlanta
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
RekruttererFase 1
- Emory University School of Medicine - Winship Cancer Institute, Atlanta
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
RekruttererFase 3
- Research Site, Atlanta
- Research Site, Atlanta
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
RekruttererFase 1/2
- Emory University, Atlanta
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
RekruttererFase 1/2
- Winship Cancer Institute - Emory University, Atlanta
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
RekruttererFase 1/2
- Emory University, Atlanta
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
RekruttererFase 1
- Winship Cancer Center - Emory University, Atlanta
BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia
RekruttererFase 1
- Winship Cancer Institute / Emory University, Atlanta
A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy
RekruttererFase 1/2
- Emory University, Atlanta
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, Atlanta
A Beta-only IL-2 ImmunoTherapY Study
RekruttererFase 1/2
- Emory - Winship Cancer Institute, Atlanta
Mavekreft-studier i andre byer
- Houston, TX42 studier
- Boston, MA32 studier
- New York City, NY31 studier
- Nashville, TN28 studier
- Baldwin Park, CA22 studier
- Los Angeles, CA22 studier
- Arlington, VA20 studier
- Dallas, TX19 studier
- San Antonio, TX19 studier
- St. Louis, MO18 studier
- Grand Rapids, MI18 studier
- Washington, DC16 studier
Andre studier i Atlanta
- Kreft (alle typer)49 studier
- Ikke-småcellet lungekreft47 studier
- Multipelt myelom42 studier
- Brystkreft41 studier
- Prostatakreft33 studier
- Akut myelogen leukemi31 studier
- Eggstokkreft29 studier
- Kolorektal kreft29 studier
- Lungekreft29 studier
- Metastatisk kreft28 studier
- Major depresjon25 studier
- Hjertesvikt25 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.